Takeda Considers Research Facility in India (India)
This article was originally published in PharmAsia News
Executive Summary
Japan's largest drug maker, Takeda, is expected to emulate fellow drug makers Daiichi Sankyo and Esai in locating research facilities in India to take advantage of lower costs. Takeda is said to be hunting for someone familiar with India to head a new division in the country. Daiichi opened an India operation in 2007 and Esai created Esai Pharmaceuticals India subsidiary. Takeda is expected to reach a final decision this year and start off with one or two products. (Click here for more